Swallowable balloon aims to help obese patients shed pounds

NCT ID NCT07647991

Completed Disease control Sponsor: Medical University of Vienna Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This small pilot study tested the safety of a swallowable intra-gastric balloon (IGBalloon) for weight loss in 5 people with obesity. Participants swallowed up to 5 balloons over 8 weeks, with regular check-ups including blood tests and endoscopies. The study also looked at weight loss and whether related health problems improved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intra-gastric balloon (IGBalloon) device
What this could lead to: If successful, this could offer a less invasive, temporary weight loss tool for people with obesity.
What could go wrong: This is a very early pilot study with only 5 participants, so results may not apply broadly. The device could cause complications requiring removal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVERSE EVENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVERSE EVENTS COMORBIDITIES WEIGHT LOSS

Contacts and locations

Locations

Medical University of Vienna

Vienna, State of Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.